The FDA approved nerandomilast (Jascayd) tablets for idiopathic pulmonary fibrosis (IPF), the first new product for the progressive lung condition in over a decade, the agency announced on Tuesday.

Filtration systems can improve indoor air quality and outcomes for patients with asthma, COPD and other respiratory diseases, ...

Cognitive impairment levels in ICU patients who had acute hypoxemic respiratory failure were similar in those with PaO2 targets of 60 and 90 mm Hg.

Adding sotatercept to standard therapy within a year of diagnosis lowers the risk for clinical worsening in patients with ...

This approach offers an excellent negative predictive value.1 However, its specificity is poor and there is an increasing ...